Global Kidney Cancer Targeted Therapy Production, Demand and Key Producers, 2022-2028

November 2022 | 111 pages | ID: G135F963D99AEN
GlobalInfoResearch

Abstracts

This report studies the global Kidney Cancer Targeted Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Kidney Cancer Targeted Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Kidney Cancer Targeted Therapy that contribute to its increasing demand across many markets.

The global Kidney Cancer Targeted Therapy market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global Kidney Cancer Targeted Therapy total market, 2017-2028, (USD Million)

Global Kidney Cancer Targeted Therapy total market by region & country, CAGR, 2017-2028, (USD Million)

U.S. VS China: Kidney Cancer Targeted Therapy total market, key domestic companies and share, (USD Million)

Global Kidney Cancer Targeted Therapy revenue by player and market share 2017-2022, (USD Million)

Global Kidney Cancer Targeted Therapy total market by Type, CAGR, 2017-2028, (USD Million)

Global Kidney Cancer Targeted Therapy total market by Application, CAGR, 2017-2028, (USD Million)

This reports profiles major players in the global Kidney Cancer Targeted Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Novartis, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Exelixis, Bayer and Eisai, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Kidney Cancer Targeted Therapy market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Kidney Cancer Targeted Therapy Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Kidney Cancer Targeted Therapy Market, Segmentation by Type

• Tyrosine Kinase Inhibitors
• mTOR Inhibitors
• EGFR Inhibitors
• Anti-VEGF Monoclonal Antibody

Global Kidney Cancer Targeted Therapy Market, Segmentation by Application

• Renal Cell Cancer
• Renal Pelvis Cancer
• Others

Companies Profiled:

• Merck
• Novartis
• Pfizer
• Roche
• Amgen
• Aveo Pharmaceuticals
• Exelixis
• Bayer
• Eisai
• Wyeth

Key Questions Answered

1. How big is the global Kidney Cancer Targeted Therapy market?

2. What is the demand of the global Kidney Cancer Targeted Therapy market?

3. What is the year over year growth of the global Kidney Cancer Targeted Therapy market?

4. What is the total value of the global Kidney Cancer Targeted Therapy market?

5. Who are the major players in the global Kidney Cancer Targeted Therapy market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Kidney Cancer Targeted Therapy Introduction
1.2 World Kidney Cancer Targeted Therapy Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Kidney Cancer Targeted Therapy Total Market by Region
  1.3.1 World Kidney Cancer Targeted Therapy Market Size by Region (2017-2028)
  1.3.2 United States Kidney Cancer Targeted Therapy Market Size (2017-2028)
  1.3.3 China Kidney Cancer Targeted Therapy Market Size (2017-2028)
  1.3.4 Europe Kidney Cancer Targeted Therapy Market Size (2017-2028)
  1.3.5 Japan Kidney Cancer Targeted Therapy Market Size (2017-2028)
  1.3.6 South Korea Kidney Cancer Targeted Therapy Market Size (2017-2028)
  1.3.7 ASEAN Kidney Cancer Targeted Therapy Market Size (2017-2028)
  1.3.8 India Kidney Cancer Targeted Therapy Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Kidney Cancer Targeted Therapy Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Kidney Cancer Targeted Therapy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 WORLD KIDNEY CANCER TARGETED THERAPY COMPANIES COMPETITIVE ANALYSIS

2.1 World Kidney Cancer Targeted Therapy Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
  2.2.1 Global Kidney Cancer Targeted Therapy Industry Rank of Major Players
  2.2.2 Global Concentration Ratios (CR4) for Kidney Cancer Targeted Therapy in 2021
  2.2.3 Global Concentration Ratios (CR8) for Kidney Cancer Targeted Therapy in 2021
2.3 Kidney Cancer Targeted Therapy Company Evaluation Quadrant
2.4 Kidney Cancer Targeted Therapy Market: Overall Company Footprint Analysis
  2.4.1 Kidney Cancer Targeted Therapy Market: Region Footprint
  2.4.2 Kidney Cancer Targeted Therapy Market: Company Product Type Footprint
  2.4.3 Kidney Cancer Targeted Therapy Market: Company Product Application Footprint
2.5 Competitive Environment
  2.5.1 Historical Structure of the Industry
  2.5.2 Barriers of Market Entry
  2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity

3 UNITED STATES VS CHINA VS REST OF THE WORLD

3.1 United States VS China: Kidney Cancer Targeted Therapy Market Comparison
  3.1.1 United States VS China: Kidney Cancer Targeted Therapy Market Size Comparison (2017 & 2021 & 2028)
  3.1.2 United States VS China: Kidney Cancer Targeted Therapy Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Kidney Cancer Targeted Therapy Major Players and Market Share, 2017-2022
  3.2.1 Major Players of Kidney Cancer Targeted Therapy in United States, Headquarters (States, Country)
  3.2.2 United States Kidney Cancer Targeted Therapy Revenue by Domestic Player, (2017-2022)
3.3 China Kidney Cancer Targeted Therapy Major Players and Market Share, 2017-2022
  3.3.1 Major Players of Kidney Cancer Targeted Therapy in China, Headquarters (Province, Country)
  3.3.2 China Kidney Cancer Targeted Therapy Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Kidney Cancer Targeted Therapy Major Players and Market Share, 2017-2022
  3.4.1 Major Players of Kidney Cancer Targeted Therapy in Rest of World, Headquarters (State, Country)
  3.4.2 Rest of World Kidney Cancer Targeted Therapy Revenue by Domestic Player, (2017-2022)

4 MARKET ANALYSIS BY TYPE

4.1 World Kidney Cancer Targeted Therapy Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
  4.2.1 Tyrosine Kinase Inhibitors
  4.2.2 mTOR Inhibitors
  4.2.3 EGFR Inhibitors
  4.2.4 Anti-VEGF Monoclonal Antibody
4.3 Market Segment by Type
  4.3.1 World Kidney Cancer Targeted Therapy Market Size by Type (2017-2022)
  4.3.2 World Kidney Cancer Targeted Therapy Market Size by Type (2023-2028)
  4.3.3 World Kidney Cancer Targeted Therapy Market Size Market Share by Type (2017-2028)

5 MARKET ANALYSIS BY APPLICATION

5.1 World Kidney Cancer Targeted Therapy Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
  5.2.1 Renal Cell Cancer
  5.2.2 Renal Pelvis Cancer
  5.2.3 Others
5.3 Market Segment by Application
  5.3.1 World Kidney Cancer Targeted Therapy Market Size by Application (2017-2022)
  5.3.2 World Kidney Cancer Targeted Therapy Market Size by Application (2023-2028)
  5.3.3 World Kidney Cancer Targeted Therapy Market Size by Application (2017-2028)

6 COMPANY PROFILES

6.1 Merck
  6.1.1 Merck Details
  6.1.2 Merck Major Business
  6.1.3 Merck Kidney Cancer Targeted Therapy Product and Services
  6.1.4 Merck Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.1.5 Merck Recent Developments/Updates
  6.1.6 Merck Competitive Strengths & Weaknesses
6.2 Novartis
  6.2.1 Novartis Details
  6.2.2 Novartis Major Business
  6.2.3 Novartis Kidney Cancer Targeted Therapy Product and Services
  6.2.4 Novartis Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.2.5 Novartis Recent Developments/Updates
  6.2.6 Novartis Competitive Strengths & Weaknesses
6.3 Pfizer
  6.3.1 Pfizer Details
  6.3.2 Pfizer Major Business
  6.3.3 Pfizer Kidney Cancer Targeted Therapy Product and Services
  6.3.4 Pfizer Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.3.5 Pfizer Recent Developments/Updates
  6.3.6 Pfizer Competitive Strengths & Weaknesses
6.4 Roche
  6.4.1 Roche Details
  6.4.2 Roche Major Business
  6.4.3 Roche Kidney Cancer Targeted Therapy Product and Services
  6.4.4 Roche Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.4.5 Roche Recent Developments/Updates
  6.4.6 Roche Competitive Strengths & Weaknesses
6.5 Amgen
  6.5.1 Amgen Details
  6.5.2 Amgen Major Business
  6.5.3 Amgen Kidney Cancer Targeted Therapy Product and Services
  6.5.4 Amgen Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.5.5 Amgen Recent Developments/Updates
  6.5.6 Amgen Competitive Strengths & Weaknesses
6.6 Aveo Pharmaceuticals
  6.6.1 Aveo Pharmaceuticals Details
  6.6.2 Aveo Pharmaceuticals Major Business
  6.6.3 Aveo Pharmaceuticals Kidney Cancer Targeted Therapy Product and Services
  6.6.4 Aveo Pharmaceuticals Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.6.5 Aveo Pharmaceuticals Recent Developments/Updates
  6.6.6 Aveo Pharmaceuticals Competitive Strengths & Weaknesses
6.7 Exelixis
  6.7.1 Exelixis Details
  6.7.2 Exelixis Major Business
  6.7.3 Exelixis Kidney Cancer Targeted Therapy Product and Services
  6.7.4 Exelixis Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.7.5 Exelixis Recent Developments/Updates
  6.7.6 Exelixis Competitive Strengths & Weaknesses
6.8 Bayer
  6.8.1 Bayer Details
  6.8.2 Bayer Major Business
  6.8.3 Bayer Kidney Cancer Targeted Therapy Product and Services
  6.8.4 Bayer Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.8.5 Bayer Recent Developments/Updates
  6.8.6 Bayer Competitive Strengths & Weaknesses
6.9 Eisai
  6.9.1 Eisai Details
  6.9.2 Eisai Major Business
  6.9.3 Eisai Kidney Cancer Targeted Therapy Product and Services
  6.9.4 Eisai Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.9.5 Eisai Recent Developments/Updates
  6.9.6 Eisai Competitive Strengths & Weaknesses
6.10 Wyeth
  6.10.1 Wyeth Details
  6.10.2 Wyeth Major Business
  6.10.3 Wyeth Kidney Cancer Targeted Therapy Product and Services
  6.10.4 Wyeth Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.10.5 Wyeth Recent Developments/Updates
  6.10.6 Wyeth Competitive Strengths & Weaknesses

7 RAW MATERIAL AND INDUSTRY CHAIN

7.1 Raw Material of Kidney Cancer Targeted Therapy and Key Manufacturers
7.2 Kidney Cancer Targeted Therapy Manufacturing Costs
7.3 Kidney Cancer Targeted Therapy Production Process
7.4 Kidney Cancer Targeted Therapy Industrial Chain

8 DISTRIBUTION CHANNEL ANALYSIS

8.1 Distribution Channel Breakdown for Kidney Cancer Targeted Therapy Shipments (%): 2017-2028
  8.1.1 Direct Channel
  8.1.2 Indirect Channel
8.2 Kidney Cancer Targeted Therapy Typical Distributors
8.3 Kidney Cancer Targeted Therapy Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Kidney Cancer Targeted Therapy Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Kidney Cancer Targeted Therapy Market Size by Region (2017-2022) & (USD Million)
Table 3. World Kidney Cancer Targeted Therapy Market Size by Region (2023-2028) & (USD Million)
Table 4. World Kidney Cancer Targeted Therapy Market Size Market Share by Region (2017-2022)
Table 5. World Kidney Cancer Targeted Therapy Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Kidney Cancer Targeted Therapy Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Kidney Cancer Targeted Therapy Players in 2021
Table 9. World Kidney Cancer Targeted Therapy Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Kidney Cancer Targeted Therapy Company Evaluation Quadrant
Table 11. Head Office of Key Kidney Cancer Targeted Therapy Player
Table 12. Kidney Cancer Targeted Therapy Market: Company Product Type Footprint
Table 13. Kidney Cancer Targeted Therapy Market: Company Product Application Footprint
Table 14. Kidney Cancer Targeted Therapy Mergers & Acquisitions Activity
Table 15. United States VS China Kidney Cancer Targeted Therapy Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Kidney Cancer Targeted Therapy in United States, Headquarters (States, Country)
Table 17. United States Kidney Cancer Targeted Therapy Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Kidney Cancer Targeted Therapy Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Kidney Cancer Targeted Therapy in China, Company Headquarters (Province, Country)
Table 20. China Kidney Cancer Targeted Therapy Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Kidney Cancer Targeted Therapy Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Kidney Cancer Targeted Therapy in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Kidney Cancer Targeted Therapy Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Kidney Cancer Targeted Therapy Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Kidney Cancer Targeted Therapy Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Kidney Cancer Targeted Therapy Revenue by Type (2017-2022) & (USD Million)
Table 27. World Kidney Cancer Targeted Therapy Revenue by Type (2023-2028) & (USD Million)
Table 28. World Kidney Cancer Targeted Therapy Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Kidney Cancer Targeted Therapy Revenue by Application (2017-2022) & (USD Million)
Table 30. World Kidney Cancer Targeted Therapy Revenue by Application (2023-2028) & (USD Million)
Table 31. Merck Basic Information, Area Served and Competitors
Table 32. Merck Major Business
Table 33. Merck Kidney Cancer Targeted Therapy Product and Services
Table 34. Merck Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Merck Recent Developments/Updates
Table 36. Merck Competitive Strengths & Weaknesses
Table 37. Novartis Basic Information, Area Served and Competitors
Table 38. Novartis Major Business
Table 39. Novartis Kidney Cancer Targeted Therapy Product and Services
Table 40. Novartis Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Novartis Recent Developments/Updates
Table 42. Novartis Competitive Strengths & Weaknesses
Table 43. Pfizer Basic Information, Area Served and Competitors
Table 44. Pfizer Major Business
Table 45. Pfizer Kidney Cancer Targeted Therapy Product and Services
Table 46. Pfizer Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Pfizer Recent Developments/Updates
Table 48. Pfizer Competitive Strengths & Weaknesses
Table 49. Roche Basic Information, Area Served and Competitors
Table 50. Roche Major Business
Table 51. Roche Kidney Cancer Targeted Therapy Product and Services
Table 52. Roche Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Roche Recent Developments/Updates
Table 54. Roche Competitive Strengths & Weaknesses
Table 55. Amgen Basic Information, Area Served and Competitors
Table 56. Amgen Major Business
Table 57. Amgen Kidney Cancer Targeted Therapy Product and Services
Table 58. Amgen Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Amgen Recent Developments/Updates
Table 60. Amgen Competitive Strengths & Weaknesses
Table 61. Aveo Pharmaceuticals Basic Information, Area Served and Competitors
Table 62. Aveo Pharmaceuticals Major Business
Table 63. Aveo Pharmaceuticals Kidney Cancer Targeted Therapy Product and Services
Table 64. Aveo Pharmaceuticals Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Aveo Pharmaceuticals Recent Developments/Updates
Table 66. Aveo Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. Exelixis Basic Information, Area Served and Competitors
Table 68. Exelixis Major Business
Table 69. Exelixis Kidney Cancer Targeted Therapy Product and Services
Table 70. Exelixis Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Exelixis Recent Developments/Updates
Table 72. Exelixis Competitive Strengths & Weaknesses
Table 73. Bayer Basic Information, Area Served and Competitors
Table 74. Bayer Major Business
Table 75. Bayer Kidney Cancer Targeted Therapy Product and Services
Table 76. Bayer Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Bayer Recent Developments/Updates
Table 78. Bayer Competitive Strengths & Weaknesses
Table 79. Eisai Basic Information, Area Served and Competitors
Table 80. Eisai Major Business
Table 81. Eisai Kidney Cancer Targeted Therapy Product and Services
Table 82. Eisai Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Eisai Recent Developments/Updates
Table 84. Wyeth Basic Information, Area Served and Competitors
Table 85. Wyeth Major Business
Table 86. Wyeth Kidney Cancer Targeted Therapy Product and Services
Table 87. Wyeth Kidney Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 88. Kidney Cancer Targeted Therapy Raw Material
Table 89. Key Manufacturers of Kidney Cancer Targeted Therapy Raw Materials
Table 90. Kidney Cancer Targeted Therapy Typical Distributors
Table 91. Kidney Cancer Targeted Therapy Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Kidney Cancer Targeted Therapy Picture
Figure 2. World Kidney Cancer Targeted Therapy Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Kidney Cancer Targeted Therapy Total Market Size (2017-2028) & (USD Million)
Figure 4. World Kidney Cancer Targeted Therapy Market Size Market Share by Region (2017-2028)
Figure 5. United States Kidney Cancer Targeted Therapy Market Size (2017-2028) & (USD Million)
Figure 6. China Kidney Cancer Targeted Therapy Market Size (2017-2028) & (USD Million)
Figure 7. Europe Kidney Cancer Targeted Therapy Market Size (2017-2028) & (USD Million)
Figure 8. Japan Kidney Cancer Targeted Therapy Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Kidney Cancer Targeted Therapy Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Kidney Cancer Targeted Therapy Market Size (2017-2028) & (USD Million)
Figure 11. India Kidney Cancer Targeted Therapy Market Size (2017-2028) & (USD Million)
Figure 12. Kidney Cancer Targeted Therapy Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Kidney Cancer Targeted Therapy by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Kidney Cancer Targeted Therapy Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Kidney Cancer Targeted Therapy Markets in 2021
Figure 17. United States VS China: Kidney Cancer Targeted Therapy Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Kidney Cancer Targeted Therapy Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Kidney Cancer Targeted Therapy Market Size Market Share by Type in 2021
Figure 20. Tyrosine Kinase Inhibitors
Figure 21. mTOR Inhibitors
Figure 22. EGFR Inhibitors
Figure 23. Anti-VEGF Monoclonal Antibody
Figure 24. World Kidney Cancer Targeted Therapy Market Size Market Share by Type (2017-2028)
Figure 25. World Kidney Cancer Targeted Therapy Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 26. World Kidney Cancer Targeted Therapy Market Size Market Share by Application in 2021
Figure 27. Renal Cell Cancer
Figure 28. Renal Pelvis Cancer
Figure 29. Others
Figure 30. World Kidney Cancer Targeted Therapy Market Size Market Share by Application (2017-2028)
Figure 31. Manufacturing Cost Structure Analysis of Kidney Cancer Targeted Therapy in 2021
Figure 32. Manufacturing Process Analysis of Kidney Cancer Targeted Therapy
Figure 33. Kidney Cancer Targeted Therapy Industrial Chain
Figure 34. Distribution Channel Breakdown for Kidney Cancer Targeted Therapy Shipments (%): 2017-2028
Figure 35. Direct Channel Pros & Cons
Figure 36. Indirect Channel Pros & Cons
Figure 37. Methodology
Figure 38. Research Process and Data Source